PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31482012-2	2019	In addition to doxorubicin, our results here indicated that camptothecin and bortezomib, which are a topoisomerase 1 poison and a 26 S proteasome inhibitor, respectively, could also induce apoptosis in a p53-dependent manner in prostate cancer.	Bortezomib	77-87	tumor protein p53	Homo sapiens	204-207	
31482012-5	2019	In contrast, p53-mediated apoptosis from bortezomib-induced stress is transcription-dependent.	Bortezomib	41-51	tumor protein p53	Homo sapiens	13-16	
31482012-7	2019	We then investigated the p53 ratio of nucleus to cytosol corresponding to low and high dose doxorubicin, camptothecin, or bortezomib treatment.	Bortezomib	122-132	tumor protein p53	Homo sapiens	25-28